UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection

Diabetes care, 2000-08, Vol.23 (8), p.1177-1181

2000

Volltextzugriff (PDF)

Therapy of chronic hepatitis C virus infection in HIV co-infected people

Current pharmaceutical design, 2004-01, Vol.10 (17), p.2111

2004

Volltextzugriff (PDF)

Assessing patients’ understanding of hepatitis C virus infection and its impact on their lifestyle

Alimentary pharmacology & therapeutics, 2006-04, Vol.23 (8), p.1161-1170

2006

Volltextzugriff (PDF)

Pancreatic hyperamylasemia during acute gastroenteritis: incidence and clinical relevance

BMC infectious diseases, 2001-09, Vol.1 (1), p.18-18, Article 18

2001

Volltextzugriff (PDF)

Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy

Alimentary pharmacology & therapeutics, 2003-09, Vol.18 (6), p.549-558

2003

Volltextzugriff (PDF)

Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital

The Journal of infection, 2005-12, Vol.51 (5), p.383-389

2005

Volltextzugriff (PDF)

A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone

Journal of viral hepatitis, 2004-11, Vol.11 (6), p.543-551

2004

Volltextzugriff (PDF)

Serum pepsinogen and gastrin levels in HIV‐positive patients: relationship with CD4+ cell count and Helicobacter pylori infection

Alimentary pharmacology & therapeutics, 2002-04, Vol.16 (4), p.807-811

2002

Volltextzugriff (PDF)

Chlamydia pneumoniae infection in HIV‐positive patients: prevalence and relationship with lipid profile

HIV medicine, 2005-01, Vol.6 (1), p.27-32

2005

Volltextzugriff (PDF)

Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study

Alimentary pharmacology & therapeutics, 1999-09, Vol.13 (9), p.1187-1193

1999

Volltextzugriff (PDF)

Interferon alfa‐2b alone or in combination with ketoprofen as treatment for interferon‐naive chronic hepatitis C patients

Alimentary pharmacology & therapeutics, 1999-10, Vol.13 (10), p.1329-1334

1999

Volltextzugriff (PDF)

Liver injury during acute gastroenteritis in adults: a retrospective study in 727 cases

Journal of hepatology, 2001-04, Vol.34, p.228

Tositti, G

2001

Volltextzugriff (PDF)

Three-Times Weekly Teicoplanin in the Outpatient Treatment of Acute Methicillin-Resistant Staphylococcal Osteomyelitis: A Pilot Study

Journal of chemotherapy (Florence), 2002-02, Vol.14 (1), p.71-75

2002

Volltextzugriff (PDF)

Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C

Journal of viral hepatitis, 2003-03, Vol.10 (2), p.111-117

2003

Volltextzugriff (PDF)

Incidence, Risk Factors, and Clinical Significance of Neurological Symptoms in Adult Patients With Acute Gastroenteritis

The American journal of gastroenterology, 1999-10, Vol.94 (10), p.3078-3079

1999

Volltextzugriff (PDF)

Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?

AIDS (London), 2007-03, Vol.21 (5), p.599-606

2007

Volltextzugriff (PDF)

Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study

Journal of acquired immune deficiency syndromes (1999), 2006-01, Vol.41 (1), p.23

2006

Volltextzugriff (PDF)

Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C

Journal of clinical virology, 2004-03, Vol.29 (3), p.160-166

2004

Volltextzugriff (PDF)

The Application of Cost Effectiveness Analysis to Derive a Formulary for Urinary Tract Infections

Journal of chemotherapy (Florence), 2002-04, Vol.14 (2), p.166-174, Article 166

2002

Volltextzugriff (PDF)

HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis C

Infection, 1998-09, Vol.26 (5), p.283-287

1998

Volltextzugriff (PDF)

Open, randomized, multicentre Italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART

Antiviral therapy, 2005-01, Vol.10 (2), p.309-317

2005

Volltextzugriff (PDF)

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

Archives of internal medicine (1960), 2002-10, Vol.162 (18), p.2125

2002

Volltextzugriff (PDF)

Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without Co-infection with hepatitis C virus

Journal of medical virology, 2003-03, Vol.69 (3), p.339-343

2003

Volltextzugriff (PDF)

Occult hepatitis B virus infection in HIV/hepatitis C virus co-infected patients

AIDS (London), 2003-07, Vol.17 (10), p.1581-1582

2003

Volltextzugriff (PDF)

Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C

The American journal of gastroenterology, 2002-02, Vol.97 (2), p.492-493

2002

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(98)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection

Therapy of chronic hepatitis C virus infection in HIV co-infected people

Assessing patients’ understanding of hepatitis C virus infection and its impact on their lifestyle

Pancreatic hyperamylasemia during acute gastroenteritis: incidence and clinical relevance

Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy

Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital

A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone

Serum pepsinogen and gastrin levels in HIV‐positive patients: relationship with CD4+ cell count and Helicobacter pylori infection

Chlamydia pneumoniae infection in HIV‐positive patients: prevalence and relationship with lipid profile

Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study

Interferon alfa‐2b alone or in combination with ketoprofen as treatment for interferon‐naive chronic hepatitis C patients

Liver injury during acute gastroenteritis in adults: a retrospective study in 727 cases

Three-Times Weekly Teicoplanin in the Outpatient Treatment of Acute Methicillin-Resistant Staphylococcal Osteomyelitis: A Pilot Study

Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C

Incidence, Risk Factors, and Clinical Significance of Neurological Symptoms in Adult Patients With Acute Gastroenteritis

Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?

Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study

Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C

The Application of Cost Effectiveness Analysis to Derive a Formulary for Urinary Tract Infections

HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis C

Open, randomized, multicentre Italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without Co-infection with hepatitis C virus

Occult hepatitis B virus infection in HIV/hepatitis C virus co-infected patients

Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C

Suchergebnisse filtern